BusinessPhoto: Mint MarketsEmcure Pharma Shares Hit Record High After Strong Q2 Results
Emcure Pharmaceuticals shares surged 16% over two sessions to reach a record high, driven by strong Q2FY27 results. The company reported a 29% increase in profit and 24% revenue growth. Analysts from Jefferies and Kotak maintained Buy ratings, highlighting growth prospects and setting target prices of ₹2,500 and ₹2,450 respectively.
Mint Markets·


